drugset / Trial / NCT01794455

Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression

NCT01794455

Phase 4 Terminated 1 enrolled Vanderbilt University
Non-randomizedSingle-groupOpen-labelBasic science

Summary

This pilot proposal will test the hypothesis that altered cerebral vessel reactivity and cerebral hypoperfusion (decreased blood flow to the brain) is a core mechanism underlying the relationship between vascular disease and depression in older adults. The long-term objective of this line of research is to: A) determine the relationship between vascular reactivity, cerebral hypoperfusion and the persistence of late-life depression and B) determine if improving cerebral perfusion with angiotensin receptor blockers (ARBs) improves depression outcomes.

Timeline

Start
2013-05
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Candesartan Unknown 32 mg
Subject Sertraline Small molecule 200 mg